Xiao, X., Han, T., Lin, X., Zhuo, M., Jiao, F., Cui, J., Qiu, X. (2025). Efficacy and safety of surufatinib (Sur) plus paclitaxel (Pac) as second line (2L) treatment for advanced gastric cancer (aGC): Final results from a phase 2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4028